Live Breaking News & Updates on Theseus Pharmaceuticals Price Performance

Stay updated with breaking news from Theseus pharmaceuticals price performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Foresite Capital Management V LLC Has $11.05 Million Position in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)

Foresite Capital Management V LLC Has $11.05 Million Position in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Quarter For Theseus Pharmaceuticals , Theseus Pharmaceuticals Price Performance , Tower Research Capital , Theseus Pharmaceuticals Inc , Foresite Capital Management , Securities Exchange Commission , Forefront Analytics , Theseus Pharmaceuticals Profile , Theseus Pharmaceuticals , Barclays Plc , News Ratings For Theseus Pharmaceuticals Daily , American International Group Inc , Free Report , Research Capital , International Group , Theseus Pharmaceuticals Daily ,

Denali Advisors LLC Increases Position in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)

Denali Advisors LLC boosted its stake in shares of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Free Report) by 675.2% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 127,900 shares of the company’s stock after purchasing an additional 111,400 shares during the period. Denali Advisors LLC owned approximately 0.29% […] ....

United States , Quarter For Theseus Pharmaceuticals , Theseus Pharmaceuticals Profile , American International Group Inc , News Ratings For Theseus Pharmaceuticals Daily , Theseus Pharmaceuticals , Tower Research Capital , Wells Fargo Company , Denali Advisors , Theseus Pharmaceuticals Inc , Theseus Pharmaceuticals Price Performance , Citigroup Inc , Free Report , Research Capital , American International Group , International Group , Get Free Report , Visit Holdingschannel , Theseus Pharmaceuticals Daily , Nasdaq Thrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Theseus Pharmaceuticals (NASDAQ:THRX) Trading Down 0.4%

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report)’s share price traded down 0.4% during trading on Tuesday . The stock traded as low as $2.27 and last traded at $2.30. 105,762 shares changed hands during trading, a decline of 68% from the average session volume of 335,687 shares. The stock had previously closed at $2.31. […] ....

Stifel Nicolaus , Theseus Pharmaceuticals Price Performance , Institutional Investors Weigh In On Theseus Pharmaceuticals , Cantor Fitzgerald , Denali Advisors , News Ratings For Theseus Pharmaceuticals Daily , Theseus Pharmaceuticals Inc , Needham Company , Affinity Asset Advisors , Jump Financial , Fairmount Funds Management , Theseus Pharmaceuticals , Get Free Report , Capital Management , Asset Advisors , Funds Management , Theseus Pharmaceuticals Daily , Nasdaq Thrx ,

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0.33) Per Share

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0.33) Per Share
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United States , Carll Gordon , Stifel Nicolaus , Barclays Plc , Theseus Pharmaceuticals , Securities Exchange Commission , Theseus Pharmaceuticals Company Profile , Theseus Pharmaceuticals Price Performance , American International Group Inc , News Ratings For Theseus Pharmaceuticals Daily , Institutional Investors Weigh In On Theseus Pharmaceuticals , Tower Research Capital , Citigroup Inc , Cantor Fitzgerald , Theseus Pharmaceuticals Inc , Needham Company , Jpmorgan Chase Co , Free Report , Theseus Pharmaceutical , Get Free Report , Research Capital , International Group , Director Carl , Exchange Commission , Theseus Pharmaceuticals Daily ,

Insider Buying: Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Director Buys 479,932 Shares of Stock

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report) Director Carl L. Gordon bought 479,932 shares of the company’s stock in a transaction on Monday, July 17th. The shares were bought at an average price of $3.05 per share, for a total transaction of $1,463,792.60. Following the completion of the acquisition, the director now directly owns […] ....

United States , Stifel Nicolaus , Carll Gordon , Cantor Fitzgerald , Needham Company , Barclays Plc , Theseus Pharmaceuticals , News Ratings For Theseus Pharmaceuticals Daily , Theseus Pharmaceuticals Inc , Hedge Funds Weigh In On Theseus Pharmaceuticals , Theseus Pharmaceuticals Price Performance , American International Group Inc , Tower Research Capital , Jpmorgan Chase Co , Get Free Report , Director Carl , Research Capital , International Group , Theseus Pharmaceuticals Daily , Nasdaq Thrx , Insider Trading , Nsider Trades ,